Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • AZN vs GSK✓SelectedUSD · GSKAZN vs GSK performance historyLatest closeAs of-0.60%11/20
Stock and ETF performance explorer

AZN vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+5,101.0%
GSK return
+922.0%
Excess return
+4,179.1%
Maximum drawdown
-48.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.6%-0.1%-0.5%-0.5%
7D-5.5%-5.3%-0.1%-2.4%
30D+3.5%-3.7%+7.2%+5.7%
3M+6.0%-7.3%+13.2%+10.6%
6M-7.0%-4.2%-2.8%-4.7%
YTD-4.2%+0.9%-5.0%-5.1%
1Y-0.7%+7.3%-7.9%-5.1%
3Y+44.1%+52.7%-8.7%+9.8%
5Y+69.6%+40.1%+29.5%+34.0%
10Y+322.3%+98.7%+223.6%+171.6%
All+5,101.0%+922.0%+4,179.1%+1,718.2%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling